傳阿斯特捷利康考慮併購必治妥施貴寶
· fortune.com
市值達 1,330 億美元的必治妥施貴寶（Bristol Myers Squibb）可望為阿斯特捷利康（AstraZeneca）提供更強大的美國市場立足點。
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to p...